Aplogies if this has been posted before.
From: "info@cannabis-med.org" <info@cannabis-med.org>
To: en@cannabis-med.org
--------------------------------------------------------
IACM-Bulletin Special of 18 August 2009
--------------------------------------------------------
* Survey on the modes of delivery of cannabinoids restarted *
Due to a problem the survey on the advantages and disadvantages
of different modes of delivery of cannabis-based drugs and
substances had to be inactivated today for about three hours and
restarted. The 140 patients who already answered the
questionnaire before 18 August 2009, 7:00 pm (time in the UK) or
2:00 pm (time in New York), are invited to answer the
questionnaire again. Sorry for any inconvenience.
Thank you very much for your participation!
People who want to support the survey are cordially invited to
spread the word on it in the internet. There are direct links to the
questionnaire in different languages:
English: http://www.cannabis-
med.org/limesurvey/index.php?sid=91387&lang=en
German: http://www.cannabis-
med.org/limesurvey/index.php?sid=91387&lang=de
Spanish: http://www.cannabis-
med.org/limesurvey/index.php?sid=91387&lang=es
French (soon available): http://www.cannabis-
med.org/limesurvey/index.php?sid=91387&lang=fr
Dutch: http://www.cannabis-
med.org/limesurvey/index.php?sid=91387&lang=nl
Anyone who uses cannabis or other cannabinoids for medicinal
purposes and has experience with two or more of the following
substances or modes of delivery is invited to participate:
- smoking of cannabis,
- inhalation of cannabis with a vaporizer,
- oral use of cannabis as a tea,
- oral use of cannabis in baked goods/cannabis tincture,
- oral use of dronabinol/Marinol (THC),
- oral use of nabilone/Cesamet,
- inhalation of dronabinol (THC) with a vaporizer,
- Sativex,
- other use.
Participants remain anonymous. The survey was approved by the
Ethics Committee of the Medical School of Hannover and is
headed by the chairwoman of the IACM, Dr. Kirsten Mueller-
Vahl, Professor at the Medical School of Hannover (Germany), in
cooperation with Dr. Arno Hazekamp of the University of Leiden
(The Netherlands), Dr. Donald Abrams, Professor at the
University of California San Francisco (USA), Dr. Ethan Russo,
Adjunct Associate Professor at the University of Montana
(USA), Dr. Franjo Grotenhermen of the nova-Institut (Germany),
Dr. Mark Ware, Assistant Professor at the McGill University,
Montreal (Canada), Dr. Ricardo Navarrete-Varo, Malaga (Spain),
and Dr. Rudolf Brenneisen, Professor at the University of Bern
(Switzerland).
The questionnaire is available at:
http://www.cannabis-med.org
International Association for Cannabis as Medicine (IACM)
Am Mildenweg 6
D-59602 Ruethen
Germany
Phone: +49 (0)2952-9708571
Fax: +49 (0)2952-902651
Email: info@cannabis-med.org
http://www.cannabis-med.org